Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/327 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME10383484
PMID: | 10383484
LR: | 20041117
CED: | 19990817
DCO: | 19990817
Titel: | Glucosamine sulfate.
Quelle: | Alternative medicine review : a journal of clinical therapeutic; VOL: 4 (3); p. 193-5 /199906/
PM: | Print
SU: | K
Sprache: | English
CY: | UNITED STATES
JID: | 9705340
ISSN: | 1089-5159
CO: | ALMRFP
DT: | Journal Article
Schlagwörter
CT: | GLUCOSAMINE/adverse effects; GLUCOSAMINE/pharmacokinetics; GLUCOSAMINE/*therapeutic use; HUMANS; OSTEOARTHRITIS/*drug therapy
CTG: | GLUCOSAMIN/unerwünschte Nebenwirkungen; GLUCOSAMIN/Pharmakokinetik; GLUCOSAMIN/*therapeutische Anwendung; MENSCH; OSTEOARTHROSE/*Arzneimitteltherapie
TE: | Glucosamine/3416-24-8
CR: | 3416-24-8
AB: | Glucosamine sulfate's role in halting or reversing joint degeneration appears to be directly due to its ability to act as an essential substrate for, and to stimulate the biosynthesis of, the glycosaminoglycans and the hyaluronic acid backbone needed for the formation of the proteoglycans found in the structural matrix of joints. Successful treatment of osteoarthritis must effectively control pain and should slow down or reverse the progression of the degeneration. Biochemical and pharmacological data combined with animal and human studies demonstrate that glucosamine sulfate is capable of satisfying both of these criteria.

» Volltext »
» Fenster schließen »